日本語English简体中文 繁體中文

4151 Kyowa Kirin Co.,Ltd.協和キリンTSE Prime / Pharmaceuticals

0 posts

Kyowa Kirin Co.,Ltd. (4151) at a glance

Code
4151
Company
Kyowa Kirin Co.,Ltd.
Local name
協和キリン
Market
TSE Prime
Sector
Pharmaceuticals
Share price
¥2,544 -23.0 (-0.90%) Nov 20 close

Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.

Kyowa Kirin Co.,Ltd. (4151) Stock Price History

Kyowa Kirin Co.,Ltd. closed at ¥2,544 on Nov 20, 2026, +7.2% over 1 month, +2.8% over 1 year.

2026-11-02 決算短信 補足資料 -2026年12月期 第3四半期- / 2026年12月期 第3四半期 決算短信〔IFRS〕(連結)¥2,621¥2,374Oct 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
1-Month High¥2,621Nov 5
1-Month Low¥2,374Oct 20
1-Week Change−1.6%vs Nov 13
1-Month Change+7.2%vs Oct 20

If you had invested ¥100,000 1 month ago, it would be worth ¥107,161 today (+7.2%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −11.9%, while this stock moved +7.2%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥2,544−23−0.90%
Nov 19 (Thu)¥2,567+14.5+0.57%
Nov 18 (Wed)¥2,553−27−1.05%
Nov 17 (Tue)¥2,580−21−0.81%
Nov 16 (Mon)¥2,601+15.5+0.60%
Nov 13 (Fri)¥2,585+23+0.90%
Nov 12 (Thu)¥2,562+61+2.44%
Nov 11 (Wed)¥2,501−10−0.40%
Nov 10 (Tue)¥2,511−22−0.87%
Nov 9 (Mon)¥2,533+106+4.37%
2026-11-02 決算短信 補足資料 -2026年12月期 第3四半期- / 2026年12月期 第3四半期 決算短信〔IFRS〕(連結)¥2,687¥2,192Aug 20Nov 20
Price5-day MA25-day MANikkei 225Disclosures
3-Month High¥2,687Sep 1
3-Month Low¥2,192Sep 11
1-Month Change+7.2%vs Oct 20
3-Month Change−3.1%vs Aug 20

If you had invested ¥100,000 3 months ago, it would be worth ¥96,914 today (−3.1%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −14.8%, while this stock moved −3.1%.

Last 10 Trading Days

DateCloseChange% Change
Nov 20 (Fri)¥2,544−23−0.90%
Nov 19 (Thu)¥2,567+14.5+0.57%
Nov 18 (Wed)¥2,553−27−1.05%
Nov 17 (Tue)¥2,580−21−0.81%
Nov 16 (Mon)¥2,601+15.5+0.60%
Nov 13 (Fri)¥2,585+23+0.90%
Nov 12 (Thu)¥2,562+61+2.44%
Nov 11 (Wed)¥2,501−10−0.40%
Nov 10 (Tue)¥2,511−22−0.87%
Nov 9 (Mon)¥2,533+106+4.37%
2026-11-02 決算短信 補足資料 -2026年12月期 第3四半期- / 2026年12月期 第3四半期 決算短信〔IFRS〕(連結)¥2,736¥2,192May 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
6-Month High¥2,736Jul 6
6-Month Low¥2,192Sep 11
3-Month Change−3.1%vs Aug 20
6-Month Change+7.0%vs May 20

If you had invested ¥100,000 6 months ago, it would be worth ¥106,981 today (+7.0%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved −5.6%, while this stock moved +7.0%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥2,544+3.2%
Oct 2026¥2,464+8.1%
Sep 2026¥2,280−13.2%
Aug 2026¥2,628+2.9%
Jul 2026¥2,555−1.3%
Jun 2026¥2,587+3.3%
May 2026¥2,505+6.1%
2026-11-02 決算短信 補足資料 -2026年12月期 第3四半期- / 2026年12月期 第3四半期 決算短信〔IFRS〕(連結)¥2,885¥2,164Nov 20Nov 20
Price25-day MA75-day MANikkei 225Disclosures
52-Week High¥2,885Feb 27
52-Week Low¥2,164Mar 5
Year to Date+0.7%vs Dec 30
From 52-Week High−11.8%Feb 27

If you had invested ¥100,000 1 year ago, it would be worth ¥102,788 today (+2.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +13.3%, while this stock moved +2.8%.

Monthly Closes

MonthMonth-End CloseMonthly %
Nov 2026¥2,544+3.2%
Oct 2026¥2,464+8.1%
Sep 2026¥2,280−13.2%
Aug 2026¥2,628+2.9%
Jul 2026¥2,555−1.3%
Jun 2026¥2,587+3.3%
May 2026¥2,505+6.1%
Apr 2026¥2,362−8.4%
Mar 2026¥2,578−10.6%
Feb 2026¥2,885+15.2%
Jan 2026¥2,505−0.9%
Dec 2025¥2,527−3.9%
Nov 2025¥2,631―
¥3,325¥2,064Nov 20, 2023Nov 20, 2026
Price13-week MA26-week MANikkei 225
3-Year High¥3,325Aug 26, 2024
3-Year Low¥2,064Feb 17, 2025
Annualized Return+1.3%
Max Drawdown−37.9%

If you had invested ¥100,000 3 years ago, it would be worth ¥103,816 today (+3.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +67.8%, while this stock moved +3.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,544+0.7%
2025¥2,527―
¥3,465¥2,064Nov 22, 2021Nov 20, 2026
Price13-week MA26-week MANikkei 225
5-Year High¥3,465Oct 24, 2022
5-Year Low¥2,064Feb 17, 2025
Annualized Return−5.3%
Max Drawdown−40.4%

If you had invested ¥100,000 5 years ago, it would be worth ¥76,168 today (−23.8%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +96.3%, while this stock moved −23.8%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,544+0.7%
2025¥2,527―
¥4,025¥492Feb 1, 2000Nov 20, 2026
Price1-year MA2-year MANikkei 225
All-Time High¥4,025Sep 2021
All-Time Low¥492Dec 2002
Total Change+77.9%vs Feb 2000
Annualized Return+2.2%

If you had invested ¥100,000 in Feb 2000, it would be worth ¥177,902 today (+77.9%).Price change only; dividends and fees are not included.

Over the same period the Nikkei 225 moved +177.5%, while this stock moved +77.9%.

Yearly Closes

YearYear-End CloseYearly %
2026 (YTD)¥2,544+0.7%
2025¥2,527+6.4%
2024¥2,376+0.2%
2023¥2,370−21.5%
2022¥3,020−3.7%
2021¥3,135+11.4%
2020¥2,814+9.4%
2019¥2,573+23.9%
2018¥2,077−4.7%
2017¥2,179+34.8%
2016¥1,616−15.6%
2015¥1,915+68.6%
2014¥1,136−2.0%
2013¥1,159+36.5%
2012¥849−9.9%
2011¥942+12.7%
2010¥836−15.1%
2009¥985+6.0%
2008¥929−22.2%
2007¥1,194+17.2%
2006¥1,019+23.8%
2005¥823+6.9%
2004¥770+12.9%
2003¥682+38.6%
2002¥492−20.9%
2001¥622−21.3%
2000¥790―

Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Feb 2000). Please check the latest prices before trading.

Kyowa Kirin Co.,Ltd. (4151) financial indicators

PER
17.8
PBR
1.47
ROE
8.26%
Dividend yield
2.75%

See all financial indicators for Kyowa Kirin Co.,Ltd. (market cap, DOE, equity ratio, EV, EBITDA, ROIC and more)

PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.

Key features of Kyowa Kirin Co.,Ltd. (4151)

Business overview

With 「キリンホールディングス」 as its parent company, the company and its 44 subsidiaries and 14 equity-method companies make and sell prescription drugs. Aiming to be a global specialty pharmaceutical company from Japan, it pursues research and development leveraging its strengths in advanced antibody technology and hematopoietic stem cell gene therapy. It focuses on disease areas such as bone and minerals and blood cancers and intractable blood disorders, handling everything from development to sales globally, while also working with partners.

Summarized from the annual securities report (fiscal year ended December 2025) filed on EDINET.

Position within Pharmaceuticals (79 companies)

Dividend yield2.75%No. 24 in the sector (highest first); median 2.97%
PER17.8xAbove the sector median of 16.5x (No. 23 from the lowest)
PBR1.47xBelow the sector median of 1.86x (No. 28 from the lowest)
ROE8.26%No. 18 in the sector (highest first); median 4.17%
Market cap¥1.3 tnNo. 8 in the sector (largest first)

Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.

Price milestones

52-week high¥2,8852/27
52-week low¥2,1643/5
Current position52.7%Where the low is 0% and the high is 100% (close on 11/20: ¥2,544)
Year to date+0.7%No. 15 of 77 in the sector (best first)
1 year+2.8%

Based on closing prices (adjusted for stock splits, excluding dividends).

Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.

Recent disclosures (TDnet, in Japanese)

Filings from the past 12 months (2).

Posts

This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.

No posts yet. Be the first to write something.

Write on the Kyowa Kirin Co.,Ltd. board

You will need this to delete your post. Please keep it safe.
By posting you agree to the board rules (Japanese). You are responsible for what you write.

More Japanese stocks in English

Japanese Stock Message Board: stocks available in English

Other boards in English